{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:19:45Z","timestamp":1790961585284,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023331","name":"LEO Pharma A\/S","doi-asserted-by":"publisher","award":["SIG2003"],"award-info":[{"award-number":["SIG2003"]}],"id":[{"id":"10.13039\/501100023331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jcyt.2023.03.015","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T01:03:07Z","timestamp":1682470987000},"page":"815-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4636-8535","authenticated-orcid":false,"given":"Ruenn Chai","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-9953","authenticated-orcid":false,"given":"Thong Teck","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Kian","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-9482","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Kiang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0001","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"Journal of Extracellular Vesicles"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0002","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1609206","article-title":"Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications","volume":"8","author":"Witwer","year":"2019","journal-title":"Journal of extracellular vesicles"},{"issue":"6","key":"10.1016\/j.jcyt.2023.03.015_bib0003","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: time to change the name!","volume":"6","author":"Caplan","year":"2017","journal-title":"Stem Cells Translational Medicine"},{"issue":"5","key":"10.1016\/j.jcyt.2023.03.015_bib0004","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"J Cell Biochem"},{"issue":"6","key":"10.1016\/j.jcyt.2023.03.015_bib0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1096\/fj.05-5211com","article-title":"Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement","volume":"20","author":"Gnecchi","year":"2006","journal-title":"Faseb J"},{"issue":"4","key":"10.1016\/j.jcyt.2023.03.015_bib0006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","article-title":"Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells","volume":"11","author":"Gnecchi","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jcyt.2023.03.015_bib0007","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.scr.2008.02.002","article-title":"Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium","volume":"1","author":"Timmers","year":"2007","journal-title":"Stem Cell Res"},{"issue":"5","key":"10.1016\/j.jcyt.2023.03.015_bib0008","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2008070798","article-title":"Mesenchymal stem cell-derived microvesicles protect against acute tubular injury","volume":"20","author":"Bruno","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jcyt.2023.03.015_bib0009","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","article-title":"Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury","volume":"4","author":"Lai","year":"2010","journal-title":"Stem Cell Res"},{"issue":"21-22","key":"10.1016\/j.jcyt.2023.03.015_bib0010","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/ten.tea.2017.0069","article-title":"Renal regenerative potential of different extracellular vesicle populations derived from bone marrow mesenchymal stromal cells","volume":"23","author":"Bruno","year":"2017","journal-title":"Tissue Engineering Part A"},{"issue":"5","key":"10.1016\/j.jcyt.2023.03.015_bib0011","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcyt.2021.01.001","article-title":"Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles","volume":"23","author":"Gimona","year":"2021","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.jcyt.2023.03.015_bib0012","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","article-title":"Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression","volume":"4","author":"Doeppner","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"10.1016\/j.jcyt.2023.03.015_bib0013","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1440-1797.2012.01589.x","article-title":"Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model","volume":"17","author":"He","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0014","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fcvm.2020.601990","article-title":"Systemic mesenchymal stem cell-derived exosomes reduce myocardial infarct size: characterization with MRI in a porcine model","volume":"7","author":"Charles","year":"2020","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"4","key":"10.1016\/j.jcyt.2023.03.015_bib0015","doi-asserted-by":"crossref","first-page":"e13337","DOI":"10.1111\/acel.13337","article-title":"Mesenchymal stem cell\u2013derived extracellular vesicles reduce senescence and extend health span in mouse models of aging","volume":"20","author":"Dorronsoro","year":"2021","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0016","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s13287-020-01887-1","article-title":"Extracellular vesicles derived from mesenchymal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome","volume":"11","author":"Accarie","year":"2020","journal-title":"Stem Cell Research & Therapy"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/03635465211068129","article-title":"Mesenchymal stem cell exosomes promote functional osteochondral repair in a clinically relevant porcine model","author":"Zhang","year":"2022","journal-title":"The American Journal of Sports Medicine"},{"issue":"5","key":"10.1016\/j.jcyt.2023.03.015_bib0018","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jcyt.2018.02.372","article-title":"Mesenchymal stromal cell exosome\u2013enhanced regulatory T-cell production through an antigen-presenting cell\u2013mediated pathway","volume":"20","author":"Zhang","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0019","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biomaterials.2019.02.006","article-title":"MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis","volume":"200","author":"Zhang","year":"2019","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jcyt.2023.03.015_bib0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/ijms22020720","article-title":"Topical application of mesenchymal stem cell exosomes alleviates the imiquimod induced psoriasis-like inflammation","volume":"22","author":"Zhang","year":"2021","journal-title":"International journal of molecular sciences"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0021","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41420-023-01335-y","article-title":"HuMSC-EV induce monocyte\/macrophage mobilization to orchestrate neovascularization in wound healing process following radiation injury","volume":"9","author":"Loinard","year":"2023","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0022","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v2i0.22614","article-title":"Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane","volume":"2","author":"Tan","year":"2013","journal-title":"Journal of extracellular vesicles"},{"issue":"4","key":"10.1016\/j.jcyt.2023.03.015_bib0023","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0024","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40824-016-0068-0","article-title":"Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases","volume":"20","author":"Nassar","year":"2016","journal-title":"Biomater Res"},{"issue":"12","key":"10.1016\/j.jcyt.2023.03.015_bib0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells and Development"},{"issue":"8","key":"10.1016\/j.jcyt.2023.03.015_bib0026","doi-asserted-by":"crossref","first-page":"e12094","DOI":"10.1002\/jev2.12094","article-title":"First-in-human intracochlear application of human stromal cell-derived extracellular vesicles","volume":"10","author":"Warnecke","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0027","doi-asserted-by":"crossref","first-page":"goac075","DOI":"10.1093\/gastro\/goac075","article-title":"Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I","volume":"10","author":"Nazari","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"3","key":"10.1016\/j.jcyt.2023.03.015_bib0028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jcyt.2015.11.018","article-title":"Safety evaluation of exosomes derived from human umbilical cord mesenchymal stromal cell","volume":"18","author":"Sun","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0029","series-title":"Oncologic Drugs Advisory Committee (ODAC) Meeting, Session on Product Characterization (AM Session)","article-title":"FDA Briefing Document","author":"Remestemcel-L","year":"2020"},{"issue":"4","key":"10.1016\/j.jcyt.2023.03.015_bib0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2023.03.015_bib0031","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","article-title":"International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials","volume":"18","author":"Galipeau","year":"2016","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.jcyt.2023.03.015_bib68","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jcyt.2023.03.008","article-title":"Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model","volume":"25","author":"Madel","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0032","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1479-5876-9-47","article-title":"Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs","volume":"9","author":"Chen","year":"2011","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.jcyt.2023.03.015_bib0033","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/ph14040345","article-title":"Assessment of tumorigenic potential in mesenchymal-stem\/stromal-cell-derived small extracellular vesicles (MSC-sEV)","volume":"14","author":"Tan","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.jcyt.2023.03.015_bib0034","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.scr.2013.01.002","article-title":"Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K\/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia\/reperfusion injury","volume":"10","author":"Arslan","year":"2013","journal-title":"Stem Cell Res"},{"issue":"4","key":"10.1016\/j.jcyt.2023.03.015_bib0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.gendis.2021.11.012","article-title":"Mesenchymal stromal cell-derived small extracellular vesicles modulate macrophage polarization and enhance angio-osteogenesis to promote bone healing","volume":"9","author":"Chuah","year":"2022","journal-title":"Genes & Diseases"},{"issue":"2_suppl","key":"10.1016\/j.jcyt.2023.03.015_bib0036","doi-asserted-by":"crossref","first-page":"254S","DOI":"10.1177\/19476035211029707","article-title":"Mesenchymal stem cell extracellular vesicles as adjuvant to bone marrow stimulation in chondral defect repair in a minipig model","volume":"13","author":"Hede","year":"2021","journal-title":"Cartilage"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0037","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41420-023-01335-y","article-title":"HuMSC-EV induce monocyte\/macrophage mobilization to orchestrate neovascularization in wound healing process following radiation injury","volume":"9","author":"Loinard","year":"2023","journal-title":"Cell Death Discov"},{"issue":"8","key":"10.1016\/j.jcyt.2023.03.015_bib0038","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.arthro.2020.03.031","article-title":"Intra-articular injections of mesenchymal stem cell exosomes and hyaluronic acid improve structural and mechanical properties of repaired cartilage in a rabbit model","volume":"36","author":"Wong","year":"2020","journal-title":"Arthroscopy: The Journal of Arthroscopic & Related Surgery"},{"issue":"11","key":"10.1016\/j.jcyt.2023.03.015_bib0039","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cells and Development"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.biomaterials.2017.11.028","article-title":"MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity","volume":"156","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0041","series-title":"Mesenchymal stem cell exosomes: the future MSC-based therapy? Mesenchymal stem cell therapy","first-page":"39","author":"Lai","year":"2013"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0042","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1073\/pnas.96.1.185","article-title":"A two-step, two-signal model for the primary activation of precursor helper T cells","volume":"96","author":"Bretscher","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.jcyt.2023.03.015_bib0043","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tibtech.2014.06.007","article-title":"Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells","volume":"32","author":"Eggermont","year":"2014","journal-title":"Trends Biotechnol"},{"issue":"1-2","key":"10.1016\/j.jcyt.2023.03.015_bib0044","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-1759(03)00010-3","article-title":"T cell stimulation and expansion using anti-CD3\/CD28 beads","volume":"275","author":"Trickett","year":"2003","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.jcyt.2023.03.015_bib0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/ijms19020530","article-title":"Role of the IL-23\/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints","volume":"19","author":"Boutet","year":"2018","journal-title":"International journal of molecular sciences"},{"issue":"1323","key":"10.1016\/j.jcyt.2023.03.015_bib0046","article-title":"The interleukin-23\/interleukin-17 axis links adaptive and innate immunity in psoriasis","volume":"9","author":"Sch\u00f6n","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0047","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13317-013-0057-4","article-title":"The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications","volume":"5","author":"Marinoni","year":"2014","journal-title":"Auto- immunity highlights"},{"issue":"6","key":"10.1016\/j.jcyt.2023.03.015_bib0048","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1111\/bjd.15533","article-title":"Interleukin (IL)-17A and IL-22\u2013producing neutrophils in psoriatic skin","volume":"177","author":"Dyring-Andersen","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0049","doi-asserted-by":"crossref","first-page":"31119","DOI":"10.1038\/srep31119","article-title":"Neutrophil extracellular trap formation is increased in psoriasis and induces human \u03b2-defensin-2 production in epidermal keratinocytes","volume":"6","author":"Hu","year":"2016","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.jcyt.2023.03.015_bib0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clinical reviews in allergy & immunology"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0051","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0052","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0053","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2018.00639","article-title":"Complement activation in inflammatory skin diseases","volume":"9","author":"Giang","year":"2018","journal-title":"Frontiers in immunology"},{"issue":"6","key":"10.1016\/j.jcyt.2023.03.015_bib0054","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/1523-1747.ep12558281","article-title":"Chemokinetic and chemotactic factors in psoriasis scale extracts","volume":"71","author":"Dahl","year":"1978","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1976.tb15529.x","article-title":"Leukotactic properties of soluble substances in psoriasis scale","volume":"95","author":"Tagami","year":"1976","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jcyt.2023.03.015_bib0056","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/1523-1747.ep12709634","article-title":"Stratum corneum activation of complement through the antibody-independent alternative pathway","volume":"92","author":"Terui","year":"1989","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jcyt.2023.03.015_bib0057","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1523-1747.ep12506623","article-title":"Immunopathology of psoriasis: a comparison with other parakeratotic lesions","volume":"78","author":"Weiss","year":"1982","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1016\/j.jcyt.2023.03.015_bib0058","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000247461","article-title":"Generation of terminal complement complexes in psoriatic lesional skin","volume":"185","author":"Takematsu","year":"1992","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jcyt.2023.03.015_bib0059","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/1523-1747.ep12558281","article-title":"Chemokinetic and chemotactic factors in psoriasis scale extracts","volume":"71","author":"Dahl","year":"1978","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0022-202X.2004.23547.x","article-title":"A proteolytic cascade of kallikreins in the stratum corneum","volume":"124","author":"Brattsand","year":"2005","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"10.1016\/j.jcyt.2023.03.015_bib0061","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/1523-1747.ep12607007","article-title":"Evidence that stratum corneum chymotryptic enzyme is transported to the stratum corneum extracellular space via lamellar bodies","volume":"104","author":"Sondell","year":"1995","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jcyt.2023.03.015_bib0062","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.1523-1747.2000.00965.x","article-title":"Identification of two secreted phospholipases A2 in human epidermis","volume":"114","author":"Maury","year":"2000","journal-title":"Journal of Investigative Dermatology"},{"issue":"48","key":"10.1016\/j.jcyt.2023.03.015_bib0063","doi-asserted-by":"crossref","first-page":"46779","DOI":"10.1074\/jbc.M207587200","article-title":"RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin","volume":"277","author":"Harder","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2023.03.015_bib0064","doi-asserted-by":"crossref","first-page":"e17581","DOI":"10.1371\/journal.pone.0017581","article-title":"DNase 2 is the main DNA-degrading enzyme of the stratum corneum","volume":"6","author":"Fischer","year":"2011","journal-title":"PloS one"},{"issue":"7","key":"10.1016\/j.jcyt.2023.03.015_bib0065","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jcyt.2021.12.003","article-title":"Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes","volume":"24","author":"Loh","year":"2022","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.jcyt.2023.03.015_bib0066","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/s41467-021-22126-y","article-title":"Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells","volume":"12","author":"Bonsergent","year":"2021","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.jcyt.2023.03.015_bib0067","article-title":"Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo","volume":"39","author":"O'Brien","year":"2022","journal-title":"Cell Reports"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923000956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923000956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:49:44Z","timestamp":1761443384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923000956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1465324923000956"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.03.015","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}